ロード中...
Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux
Nonalcoholic fatty liver disease (NAFLD) is a kind of liver lipid synthesis and degradation imbalance related with metabolic syndrome. Celecoxib shows the function of ameliorating NAFLD, but the underlying mechanisms remain unknown. Here, we discuss the possible mechanisms of celecoxib alleviating N...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5841322/ https://ncbi.nlm.nih.gov/pubmed/29515134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-22339-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|